Palisade Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-53,306
Closed -$1.82M – 531
2016
Q1
$1.82M Sell
53,306
-11,451
-18% -$452K 0.06% 355
2015
Q4
$5.14M Sell
64,757
-48,132
-43% -$3.37M 0.17% 200
2015
Q3
$6.62M Buy
112,889
+25,845
+30% +$1.71M 0.2% 185
2015
Q2
$5.6M Sell
87,044
-2,292
-3% -$140K 0.14% 249
2015
Q1
$5.45M Sell
89,336
-41,660
-32% -$2.85M 0.14% 258
2014
Q4
$7.67M Buy
130,996
+1,422
+1% +$72.4K 0.19% 202
2014
Q3
$5.55M Buy
+129,574
New +$5.81M 0.14% 267

Other funds holding ALKS

Palisade Capital Management's ALKS Position: Q2 2016 in Review

Palisade Capital Management sold out of Alkermes (ALKS) in Q2 2016, closing a stake of 53,306 shares — an estimated $1.82M sold.

Palisade Capital Management first reported a position in ALKS in Q3 2014 and held it in 7 quarters. The position peaked at $7.67M in Q4 2014. 246 funds tracked by Wall St. Rank hold ALKS as of Q2 2016.

  • Palisade Capital Management reported no remaining Alkermes position as of Q2 2016 after selling out during the quarter.
  • Palisade Capital Management sold 53,306 Alkermes shares in Q2 2016, an estimated $1.82M.
  • Palisade Capital Management first reported a position in Alkermes in Q3 2014 and held it in 7 quarters.
  • Palisade Capital Management's Alkermes position peaked at $7.67M in Q4 2014.
  • 246 funds tracked by Wall St. Rank held Alkermes as of Q2 2016.

Based on Palisade Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.